e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Current issues in malignant pleural diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The referral to diagnosis time for patients with malignant effusions presenting to a respiratory pleural clinic
J. Walters, A. Srivastava, N. M. Foley (Bath, United Kingdom)
Source:
Annual Congress 2010 - Current issues in malignant pleural diseases
Session:
Current issues in malignant pleural diseases
Session type:
Thematic Poster Session
Number:
3324
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Walters, A. Srivastava, N. M. Foley (Bath, United Kingdom). The referral to diagnosis time for patients with malignant effusions presenting to a respiratory pleural clinic. Eur Respir J 2010; 36: Suppl. 54, 3324
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The effect of a pleural diseases clinic on pleural effusion admission rates
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Role of medical thoracoscopy in diagnosis of recurrent undiagnosed pleural effusion
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Medical thoracoscopy for diagnosis of pleural effusion in cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004
A 10-year experience of pleurodesis for malignant pleural effusion in a district general hospital
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Symptoms, emergency admissions and place of death in patients with pleural malignancy
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
The necessity of examination of patients with pleural effusions by oncological programme
Source: Eur Respir J 2006; 28: Suppl. 50, 75s
Year: 2006
Pleural effusions in medical ICU –prevalence, causes and clinical significance
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006
Algorithm for diagnostics of recurrent pleural effusions suspected to malignancy
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
Influence of psychological distress on symptom burden of patients admitted by malignant pleural effusion
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020
The importance of intrapleurally γ-interferon in ambulatory management of malignant pleural effusion in elderly patients with end-stage NSCCL
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005
Optimal management of symptomatic malignant pleural effusions: individualised care
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021
Correlation of accompanying pleural effusion with patient characteristics and mortality in patients with community acquired pneumonia
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Eozinophylia syndrom of pleural effusion to patients of different age
Source: Eur Respir J 2004; 24: Suppl. 48, 629s
Year: 2004
The management of benign non-infective pleural effusions
Source: Eur Respir Rev 2016; 25: 303-316
Year: 2016
Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017
Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept